GwilliamG
Posted - 2 days ago
$ATNM -- Reminder team -- the KOL call is 8AM EDT Monday morning. Gotta love the timing (for us MT and PT folks).....VERY pre-market Register here...https://lifescievents.com/event/actinium/ Got any predictions for the CAR-T partner? $NVS or $GILD
GwilliamG
Posted - 2 days ago
@resume777 @TechGal -- gotta be $GILD --- I feel like $NVS had their shot at this last year.....and well, here we are....
100dollars
Posted - 3 days ago
$IBRX $MRK $AZN $NVS $BMY come to mama
DonCorleone77
Posted - 3 days ago
$MOR $NVS Novartis meets all tender offer conditions to acquire MorphoSys Novartis BidCo AG, an indirect wholly owned subsidiary of Novartis AG (NVS), announced the result of its voluntary public takeover offer for the shares of MorphoSys AG (MOR), including all shares represented by MorphoSys American Depositary Shares, or "ADS.". As of the expiry of the acceptance period at 24:00 hours CEST on May 13, the offer has been accepted by approximately 79.6% of the total share capital of MorphoSys, including purchases by Novartis BidCo AG outside the offer for approximately 11.6% of the share capital. All conditions of the offer, including the minimum acceptance threshold of 65%, were fulfilled by the end of the acceptance period. The settlement of the shares tendered during the initial acceptance period is scheduled for May 23. "With all offer conditions fulfilled, Novartis can now begin the necessary steps to progress the integration of MorphoSys, including full access to pelabresib (CPI-0610), a novel BET inhibitor in combination with ruxolitinib for patients with myelofibrosis. The integration also allows full access to tulmimetostat (CPI-0209), an early-stage investigational dual inhibitor of EZH1 and EZH2 currently being tested in patients with solid tumors or lymphomas, as well as a broad portfolio of partnered assets, some of which are in partnership with Novartis, including ianalumab (VAY736). In the context of the integration Novartis continues to progress the workstreams for implementation of both a delisting of MorphoSys and a domination and profit and loss transfer agreement with MorphoSys," the company stated.
100dollars
Posted - 3 days ago
$IBRX who will be the sole owner of this $MRK 131
$AZN 77
$NVS 103
$BMY 44
KenFaulkenberry
Posted - 3 days ago
My Favorite Healthcare Stocks in Each Dividend Value Builder Risk/Stability Grade: Symbol - Company Name (Risk/Stability Grade) - Yield $JNJ - Johnson & Johnson (A) - 3.2% $NVS - Novartis AG (B) - 3.7% $BMY - Bristol-Myers Squibb (C) - 5.4% $WBA - Walgreens Boots Alliance (D) - 5.6% $CVS - CVS Health (D) - 4.7%
neofeudal
Posted - 3 days ago
@Tonee1234 The parallels in treatment goals between Coherus Tori+chemo and the BMS failed P3 trial are striking, as is the difference in efficacy. I truly believe that Tori is going to be confirmed as *the* PD-1 to use for lung cancer, just as it is for NPC. The evidence is already solid that Tori rocks on lung cancer (standard of care in China)...and there are 221,000 Americans per year who could benefit from Tori. It costs $6,000 per lung cancer patient per month for chemo. Take $2,000 per month for Tori (conservatively) and that's $44 million per month, or an increase in CHRS quarterly revenue of 145%! One indication, doubles the SP. But many others are likely...the Cancer Research Institute believes it! And them there's Udenyca, the pipeline... $CHRS $BMY $PFE $NVS
SilverEagle
Posted - 4 days ago
$NVS looking great
Mergerbrief
Posted - 6 days ago
$MOR $NVS - Tender Offer Expires 5pm MergerBrief.com
Diefreeandsell
Posted - 1 week ago
@johnnybokc got approved for multiple sclerosis drug Briumvi in Dec 2022 and slowly taking mkt share from ocrevus $RHHBY and kesimpta $NVS .
Nosferatus
Posted - 1 week ago
$MCRB $XBI $NVS $RHHBY $SPX please watch this video from minute 15. we will soon be bought at a minimum of USD 10 per share https://youtu.be/94NcNu12hDE?si=yAmH6VNYX6XFQ18E
robo84
Posted - 1 week ago
$JAGX She will take Jaguar forward with her professional expertise. Take a look at her biography and see which top companies she has headed, e.g. Merck/Novartis
$MRK $NVS $IRWD
OG_Tigress
Posted - 1 week ago
$WAVD this management team is stacked. Not only have they achieved FDA 510K clearance, their product is validated by collaborations with $TAK and $NVS. Company has largest EEG & ERP database recordings consisting of 15 years of research, $80M+ and 8 patents across 12 disorders.
DefenseMania
Posted - 1 week ago
Arcus Biosciences Reports First-Quarter 2024 Financial Results and Provides a Pipeline Update | $ABBV $BMY $NVS $LLY NICE REPORT ! https://www.stocktitan.net/news/RCUS/arcus-biosciences-reports-first-quarter-2024-financial-results-and-32di7in4knux.html
robo84
Posted - 1 week ago
$JAGX I like how Jaguar unexpectedly releases news...and the bears then quickly run away. Now would be just the right time. 1$ is coming soon
$NVS
SilverEagle
Posted - 1 week ago
$NVS RSI crossing over. 👀
digitalcori
Posted - 1 week ago
💼 💰 Dive into the secrets of Tweedy Browne's $2.07B portfolio! 📈 Discover their winning strategies and market insights that made them a titan in finance! #Investing #Finance 💰 Top Sells: $FMC, $KOF, $VZ, $UL, and $NVS https://tickertracker.io/articles/ng0504g8xp-tweedy-browne-s-q1-2024-portfolio-navigating-volatility-and-capitalizing-on-opportunities
GwilliamG
Posted - 1 week ago
@Biotrad3r @FonsieTrader --- and according to the DD done by @resume777 (prime stuff as always Ray) currently only yescarta ($GILD) and kymriah ($NVS) are being used at UTSW
GwilliamG
Posted - 1 week ago
@resume777 @mauryrosen @Karmic @DWTW -- so we are really just down to $GILD and $NVS -- this is going to be fun.....I'm pulling for $GILD fwiw
GwilliamG
Posted - 1 week ago
@Biotrad3r @FonsieTrader -- that KOL call should give you a good idea of who might be in line.....six approved CAR-T therapies..... 1. $GILD - yescarta, tecartus 2. $NVS - kymriah 3. $BMY -- abecma, breyanzi 4. $JNJ - carvykti who needs it the most?
GwilliamG
Posted - 1 week ago
@DWTW @resume777 @mauryrosen -- it should tell us a heck of a lot about who might be first in line for a "deeper relationship" --- Let me know if I'm missing anyone but the players are: 1. $GILD - yescarta, tecartus 2. $NVS - kymriah 3. $BMY -- abecma, breyanzi 4. $JNJ - carvykti am i missing anyone....? @Karmic - @resume777 ....this is going to be a fun KOL-call
DaStockAnalyst_
Posted - 1 week ago
Radiopharma stocks higher as sector welcomes the latest M&A deal https://seekingalpha.com/news/4099035-novartis-mariana-oncology-deal-drives-radiopharma ..Shares of radiopharma companies spiked Thursday as investors welcomed the latest M&A deal to hit the sector.... $NVS $CATX $CLRB ATNM . for more info click here https://shorturl.at/hoU47
FonsieTrader
Posted - 1 week ago
$NVS $AZN $LLY "Radiopharma stocks higher as sector welcomes the latest M&A deal" a very good read https://seekingalpha.com/news/4099035-novartis-mariana-oncology-deal-drives-radiopharma
seforim
Posted - 1 week ago
$NVS $MOR $ABBV $INCY $KPTI Vote. Poll redo, will Novartis back out of Morphosys acquisition? https://x.com/kinatsofrim/status/1787532464623071341
cubie
Posted - 1 week ago
just realized cubie tagged $nvs meant $nvo. no one corrected cubie🙄. shows how much peeps paying attention 😑😅🙄😅
cubie
Posted - 1 week ago
$AMGN $MDGL $VKTX $NVS $LLY Lilly just needed extra dayðŸ¤ðŸ˜†ðŸ˜…
DefenseMania
Posted - 2 weeks ago
$PFE is there a vaccine that would help humans stop trans-gendering ? Now that would be a money maker !!!
$ABBV $AMGN $NVS
Jacobi
Posted - 2 weeks ago
$ABBV $GLYC $JAZZ $NVS else all your pumping would have been for nothing.
